Pharmacological bridge to cardiac transplantation: current limitations.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8417706.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Addition of intravenous enoximone to sympathomimetic agents permits a rapid and drastic improvement in the clinical and hemodynamical condition of patients in cardiogenic shock referred for a mechanical bridge to transplantation. The present experience, based on the management of 52 patients, permits us to point out the current limitations of this pharmacological bridge: the rate of sudden death, the incompleteness of the physical rehabilitation of the patients, and the vanishing effect of intravenous enoximone.
Medical subject headings
- Assisted Circulation
- Enoximone
- Heart Failure
- Heart Transplantation